Redirecting the revolution: new developments in drug development for psychiatry
- Expert Opin Drug Discov. 2019 Dec;14(12):1213-1219. doi: 10.1080/17460441.2019.1666102.
Affiliations
- 1. Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health , Bethesda , MD , USA.
- 2. National Institute of Mental Health , Bethesda , MD , USA.
PMID: 31545131
DOI: 10.1080/17460441.2019.1666102
Keywords
Autism spectrum disorder; biomarkers; bipolar disorder; major depressive disorder; psychiatric drug discovery; psychiatric genetics; public-private partnerships; schizophrenia; therapeutics; treatment-resistant depression.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease
-
target: Reference Standards; Trace Amine-associated Receptor (TAAR); 5-HT Receptor; Dopamine ReceptorResearch Areas: Neurological Disease